| The interpaly between immune system and microbiota in gynecological diseases: a narrative review. P Villa, C Cipolla, S D'Ippolito, ID Amar, M Shachor, F Ingravalle, ... European review for medical and pharmacological sciences, 5676-5690, 2020 | 33 | 2020 |
| The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease LR Lopetuso, S Deleu, L Godny, V Petito, P Puca, F Facciotti, H Sokol, ... Gut 72 (9), 1642-1650, 2023 | 25 | 2023 |
| Bile acid-related regulation of mucosal inflammation and intestinal motility: from pathogenesis to therapeutic application in IBD and microscopic colitis F Di Vincenzo, P Puca, LR Lopetuso, V Petito, L Masi, B Bartocci, ... Nutrients 14 (13), 2664, 2022 | 20 | 2022 |
| Role of Multiparametric Intestinal Ultrasound in the Evaluation of Response to Biologic Therapy in Adults with Crohn’s Disease P Puca, LE Del Vecchio, ME Ainora, A Gasbarrini, F Scaldaferri, ... Diagnostics 12 (8), 1991, 2022 | 9 | 2022 |
| Bacillus Clausii (O/C, SIN, N/R, T) Improves Acute Mild Colitis in Mice while In-Vivo Modulating Gut Microbiota F Scaldaferri, C Graziani, V Mora, V Petito, LR Lopetuso, P Puca, G Ianiro, ... Annals of gastroenterology and the digestive system, 2021 | 7 | 2021 |
| Glucagon-like peptide-2 analogues for Crohn’s disease patients with short bowel syndrome and intestinal failure M Pizzoferrato, P Puca, S Ennas, G Cammarota, L Guidi World Journal of Gastroenterology 28 (44), 6258, 2022 | 6 | 2022 |
| Gut microbiota signatures are associated with psychopathological profiles in patients with ulcerative colitis: results from an Italian tertiary IBD center F Scaldaferri, AM D’Onofrio, R Calia, F Di Vincenzo, GF Ferrajoli, V Petito, ... Inflammatory Bowel Diseases 29 (11), 1805-1818, 2023 | 5 | 2023 |
| Adverse Food Reactions in Inflammatory Bowel Disease: State of the Art and Future Perspectives I Capobianco, F Di Vincenzo, P Puca, G Becherucci, MC Mentella, ... Nutrients 16 (3), 351, 2024 | 1 | 2024 |
| Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study LR Lopetuso, L Laterza, V Petito, S Pecere, G Quaranta, F Del Chierico, ... Microorganisms 11 (10), 2536, 2023 | 1 | 2023 |
| Clinical assessment of Crohn perianal abscesses and fistulas P Puca, LR Lopetuso, L Laterza, M Pizzoferrato, F Scaldaferri Anal Fistula and Abscess, 113-126, 2022 | 1 | 2022 |
| OC. 07.9: ENDOSCOPIC BALLOON DILATION ASSOCIATED WITH BIOLOGICAL THERAPY IN CROHN'S DISEASE STRICTURES: A SINGLE CENTER EXPERIENCE LR Lopetuso, G Coppola, N Alfieri, C Morretta, F Di Vincenzo, P Puca, ... Digestive and Liver Disease 56, S167, 2024 | | 2024 |
| T. 08.9: SPECIFIC GUT MICROBIOTA SIGNATURES ARE ASSOCIATED WITH SYMPTOMATIC LACTOSE MALABSORPTION I Capobianco, C Graziani, F Del Chierico, P Puca, F Di Vincenzo, ... Digestive and Liver Disease 56, S265, 2024 | | 2024 |
| T. 11.2: SARCOPENIA AND IBD: MOLECULAR PATHWAYS AND POTENTIAL PHARMACOLOGICAL AND MICROBIAL MODULATORS IN INVITRO MODELS OF INFLAMMATORY BOWEL DISEASE V Petito, S Troisi, L Masi, V Emoli, LR Lopetuso, F Di Vincenzo, P Puca, ... Digestive and Liver Disease 56, S277, 2024 | | 2024 |
| Cellular and Molecular Determinants of Biologic Drugs Resistance and Therapeutic Failure in Inflammatory Bowel Disease P Puca, I Capobianco, G Coppola, F Di Vincenzo, V Trapani, V Petito, ... International Journal of Molecular Sciences 25 (5), 2789, 2024 | | 2024 |
| The effects of Escherichia coli Nissle 1917 on the gut microbiota composition in ulcerative colitis patients P Puca, F Del Chierico, C Graziani, L Masi, G Coppola, F Di Vincenz, ... JOURNAL OF CROHNS & COLITIS 18, I2144-I2144, 2024 | | 2024 |
| Endoscopic balloon dilation associated with biological therapy in Crohn's Disease strictures: a single center experience LR Lopetuso, G Coppola, N Alfieri, C Morretta, F Di Vincenzo, P Puca, ... JOURNAL OF CROHNS & COLITIS 18, I1391-I1392, 2024 | | 2024 |
| Organic Cation Transporter (OCTN)-1 variants shape innate immunity and predict individual response to vedolizumab In ulcerative colitis patients I Capobianco, P Puca, L Masi, V Petito, PC Pafundi, M De Felice, ... JOURNAL OF CROHNS & COLITIS 18, I388-I389, 2024 | | 2024 |
| An Integrative Multi-omic Analysis defines Gut Microbiota, Mycobiota and Metabolic fingerprints in Ulcerative Colitis Patients M Scanu, F Toto, V Petito, L Masi, M Fidaleo, P Puca, V Baldelli, S Reddel, ... Frontiers in Cellular and Infection Microbiology 14, 1366192, 2024 | | 2024 |
| P1213 The effects of Escherichia coli Nissle 1917 on the gut microbiota composition in ulcerative colitis patients P Puca, F Del Chierico, C Graziani, L Masi, G Coppola, F Di Vincenz, ... Journal of Crohn's and Colitis 18 (Supplement_1), i2157-i2157, 2024 | | 2024 |
| P109 Organic Cation Transporter (OCTN)-1 variants shape innate immunity and predict individual response to vedolizumab In ulcerative colitis patients I Capobianco, P Puca, L Masi, V Petito, PC Pafundi, M De Felice, ... Journal of Crohn's and Colitis 18 (Supplement_1), i392-i393, 2024 | | 2024 |
